Eton Pharmaceutical
ETON
54.88
+0.11
+0.20%
Eton Pharmaceutical
US · ETON
#2944 by market cap
Listed 2018
54.88
+0.11
+0.20%
Live - 5344 symbols - heartbeat 45s ago
· 2026-10-08 08:16
Pre-market
54.60
-0.51%
After-hours
55.10
+0.40%
- Market cap
- 1.57B
- P/E (TTM)i
- 140.72
- P/Bi
- 33.67
- EPSi
- -0.17
- Div yieldi
- 0.00%
- 52W posi
- 78%
Reader sentiment
Are you bullish or bearish on ETON?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 3 analysts
Buy
Avg price target
68.67 +25.1%
Price target rangecurrent 54.88
Low60.00
Avg68.67
High76.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-01 | H.C. Wainwright | -- | BUY | 70.00 |
| 2026-08-14 | Craig-Hallum | -- | BUY | 76.00 |
| 2026-08-14 | H.C. Wainwright | -- | BUY | 70.00 |
| 2026-08-13 | Craig-Hallum | -- | BUY | 62.00 |
| 2026-08-11 | H.C. Wainwright | -- | BUY | 65.00 |
| 2026-07-30 | CCORF | -- | BUY | 60.00 |
| 2026-07-28 | Craig-Hallum | -- | BUY | 62.00 |
| 2026-07-17 | CCORF | -- | BUY | 60.00 |
| 2026-07-16 | CCORF | -- | BUY | 60.00 |
| 2026-07-01 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-06-25 | B. Riley Securities | -- | BUY | 40.00 |
| 2026-05-21 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-05-20 | Craig-Hallum | -- | BUY | -- |
| 2026-05-18 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-05-15 | B. Riley Securities | -- | BUY | 40.00 |
| 2026-05-15 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-05-12 | H.C. Wainwright | -- | BUY | 52.00 |
| 2026-05-04 | Craig-Hallum | -- | BUY | 40.00 |
| 2026-05-01 | Craig-Hallum | -- | BUY | -- |
| 2026-05-01 | B. Riley Securities | -- | BUY | 31.00 |
| 2026-04-27 | Craig-Hallum | -- | BUY | -- |
| 2026-04-16 | Craig-Hallum | -- | BUY | -- |
| 2026-03-20 | Craig-Hallum | -- | BUY | 35.00 |
| 2026-03-20 | B. Riley Securities | -- | BUY | 31.00 |
| 2026-03-20 | H.C. Wainwright | -- | BUY | 52.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-13 | After close | ±12.32% | +44.26% (beat) |
| 2026/Q1 | 2026-05-14 | After close | ±12.94% | +1.00% (in line) |
| 2025/Q4 | 2026-03-19 | After close | ±24.19% | +7.46% (in line) |
| 2025/Q3 | 2025-11-06 | After close | ±19.51% | -11.70% (in line) |
| 2025/Q2 | 2025-08-07 | After close | ±16.86% | +12.32% (in line) |
| 2025/Q1 | 2025-05-13 | After close | ±14.43% | +0.29% (in line) |
| 2024/Q4 | 2025-03-18 | -- | ±20.27% | -3.99% (in line) |
| 2024/Q3 | 2024-11-12 | After close | -- | +15.59% |
| 2024/Q2 | 2024-08-08 | After close | ±37.29% | +2.76% (in line) |
| 2024/Q1 | 2024-05-09 | After close | ±35.81% | -0.15% (in line) |
| 2023/Q4 | 2024-03-14 | After close | -- | -13.68% |
| 2023/Q3 | 2023-11-09 | -- | ±39.85% | -15.23% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:16:07 · For reference only, not investment advice and not tailored to your situation.